Oral Anticoagulants Market 2027 By Product, Indication, Distribution Channel | The Insight Partners

Oral Anticoagulants Market to 2027 - Global Analysis and Forecasts By Product (Novel Oral Anticoagulant, Warfarin); Indication (Atrial Fibrillation (AF) or Stroke Prevention, Deep Vein Thrombosis And Pulmonary Embolism,); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce)

Report Code: TIPRE00004771 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Anticoagulants are drugs that are added to the blood to prevent blot clotting. These are often used for the prevention of blood clots in the veins or arteries or to prevent the enlargement of a clot that may circulate in the blood stream.

MARKET DYNAMICS
The Oral Anticoagulants market is anticipated to grow in the forecast, owing to the factors such as rising cardiovascular diseases, growing geriatric population and increasing surgical procedures. Nevertheless, high cost associated with the oral anticoagulant drugs is expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Oral Anticoagulants Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Oral Anticoagulants market with detailed market segmentation by Product, Indication, Distribution Channel and geography. The global Oral Anticoagulants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Oral Anticoagulants market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Oral Anticoagulants market is segmented on the basis of Product, Indication and Distribution Channel. Based on Product the market is segmented into Novel Oral Anticoagulant, Warfarin. Based on Indication the market is segmented into Atrial Fibrillation (AF)/ Stroke Prevention, Deep Vein Thrombosis And Pulmonary Embolism. Based on Distribution Channel the market is segmented into Hospital Pharmacies, Retail Pharmacies, E-Commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Oral Anticoagulants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Oral Anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Oral Anticoagulants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral Anticoagulants market in these regions.

MARKET PLAYERS
The reports cover key developments in the Oral Anticoagulants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Oral Anticoagulants market are anticipated to lucrative growth opportunities in the future with the rising demand for Oral Anticoagulants market in the global market. Below mentioned is the list of few companies engaged in the Oral Anticoagulants market.

The report also includes the profiles of Oral Anticoagulants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Cipla Limited
  • Medicure
  • Eisai Co., Ltd
  • GlaxoSmithKline Plc
  • Eli Lilly And Company
  • Abbott Laboratories
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company Ltd
  • Pfizer Inc
  • AstraZeneca, PLC
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Anticoagulants Market - By Product
1.3.2 Oral Anticoagulants Market - By Indication
1.3.3 Oral Anticoagulants Market - By Distribution Channel
1.3.4 Oral Anticoagulants Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL ANTICOAGULANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL ANTICOAGULANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ORAL ANTICOAGULANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL ANTICOAGULANTS - GLOBAL MARKET OVERVIEW
6.2. ORAL ANTICOAGULANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. NOVEL ORAL ANTICOAGULANT
7.3.1. Overview
7.3.2. Novel Oral Anticoagulant Market Forecast and Analysis
7.3.3. Rivaroxaban Market
7.3.3.1. Overview
7.3.3.2. Rivaroxaban Market Forecast and Analysis
7.3.4. Apixaban Market
7.3.4.1. Overview
7.3.4.2. Apixaban Market Forecast and Analysis
7.3.5. Dabigatran Market
7.3.5.1. Overview
7.3.5.2. Dabigatran Market Forecast and Analysis
7.3.6. Edoxaban Market
7.3.6.1. Overview
7.3.6.2. Edoxaban Market Forecast and Analysis
7.3.7. Betrixaban Market
7.3.7.1. Overview
7.3.7.2. Betrixaban Market Forecast and Analysis
7.4. WARFARIN
7.4.1. Overview
7.4.2. Warfarin Market Forecast and Analysis
8. ORAL ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ATRIAL FIBRILLATION (AF) OR STROKE PREVENTION
8.3.1. Overview
8.3.2. Atrial Fibrillation (AF) or Stroke Prevention Market Forecast and Analysis
8.4. DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
8.4.1. Overview
8.4.2. Deep Vein Thrombosis And Pulmonary Embolism Market Forecast and Analysis
8.5.
8.5.1. Overview
8.5.2. Market Forecast and Analysis
9. ORAL ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. E-Commerce Market Forecast and Analysis
10. ORAL ANTICOAGULANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oral Anticoagulants Market Overview
10.1.2 North America Oral Anticoagulants Market Forecasts and Analysis
10.1.3 North America Oral Anticoagulants Market Forecasts and Analysis - By Product
10.1.4 North America Oral Anticoagulants Market Forecasts and Analysis - By Indication
10.1.5 North America Oral Anticoagulants Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Oral Anticoagulants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oral Anticoagulants Market
10.1.6.1.1 United States Oral Anticoagulants Market by Product
10.1.6.1.2 United States Oral Anticoagulants Market by Indication
10.1.6.1.3 United States Oral Anticoagulants Market by Distribution Channel
10.1.6.2 Canada Oral Anticoagulants Market
10.1.6.2.1 Canada Oral Anticoagulants Market by Product
10.1.6.2.2 Canada Oral Anticoagulants Market by Indication
10.1.6.2.3 Canada Oral Anticoagulants Market by Distribution Channel
10.1.6.3 Mexico Oral Anticoagulants Market
10.1.6.3.1 Mexico Oral Anticoagulants Market by Product
10.1.6.3.2 Mexico Oral Anticoagulants Market by Indication
10.1.6.3.3 Mexico Oral Anticoagulants Market by Distribution Channel
10.1.6.4 US Oral Anticoagulants Market
10.1.6.4.1 US Oral Anticoagulants Market by Product
10.1.6.4.2 US Oral Anticoagulants Market by Indication
10.1.6.4.3 US Oral Anticoagulants Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Oral Anticoagulants Market Overview
10.2.2 Europe Oral Anticoagulants Market Forecasts and Analysis
10.2.3 Europe Oral Anticoagulants Market Forecasts and Analysis - By Product
10.2.4 Europe Oral Anticoagulants Market Forecasts and Analysis - By Indication
10.2.5 Europe Oral Anticoagulants Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Oral Anticoagulants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oral Anticoagulants Market
10.2.6.1.1 Germany Oral Anticoagulants Market by Product
10.2.6.1.2 Germany Oral Anticoagulants Market by Indication
10.2.6.1.3 Germany Oral Anticoagulants Market by Distribution Channel
10.2.6.2 France Oral Anticoagulants Market
10.2.6.2.1 France Oral Anticoagulants Market by Product
10.2.6.2.2 France Oral Anticoagulants Market by Indication
10.2.6.2.3 France Oral Anticoagulants Market by Distribution Channel
10.2.6.3 Italy Oral Anticoagulants Market
10.2.6.3.1 Italy Oral Anticoagulants Market by Product
10.2.6.3.2 Italy Oral Anticoagulants Market by Indication
10.2.6.3.3 Italy Oral Anticoagulants Market by Distribution Channel
10.2.6.4 Spain Oral Anticoagulants Market
10.2.6.4.1 Spain Oral Anticoagulants Market by Product
10.2.6.4.2 Spain Oral Anticoagulants Market by Indication
10.2.6.4.3 Spain Oral Anticoagulants Market by Distribution Channel
10.2.6.5 United Kingdom Oral Anticoagulants Market
10.2.6.5.1 United Kingdom Oral Anticoagulants Market by Product
10.2.6.5.2 United Kingdom Oral Anticoagulants Market by Indication
10.2.6.5.3 United Kingdom Oral Anticoagulants Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oral Anticoagulants Market Overview
10.3.2 Asia-Pacific Oral Anticoagulants Market Forecasts and Analysis
10.3.3 Asia-Pacific Oral Anticoagulants Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Oral Anticoagulants Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Oral Anticoagulants Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Oral Anticoagulants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oral Anticoagulants Market
10.3.6.1.1 Australia Oral Anticoagulants Market by Product
10.3.6.1.2 Australia Oral Anticoagulants Market by Indication
10.3.6.1.3 Australia Oral Anticoagulants Market by Distribution Channel
10.3.6.2 China Oral Anticoagulants Market
10.3.6.2.1 China Oral Anticoagulants Market by Product
10.3.6.2.2 China Oral Anticoagulants Market by Indication
10.3.6.2.3 China Oral Anticoagulants Market by Distribution Channel
10.3.6.3 India Oral Anticoagulants Market
10.3.6.3.1 India Oral Anticoagulants Market by Product
10.3.6.3.2 India Oral Anticoagulants Market by Indication
10.3.6.3.3 India Oral Anticoagulants Market by Distribution Channel
10.3.6.4 Japan Oral Anticoagulants Market
10.3.6.4.1 Japan Oral Anticoagulants Market by Product
10.3.6.4.2 Japan Oral Anticoagulants Market by Indication
10.3.6.4.3 Japan Oral Anticoagulants Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oral Anticoagulants Market Overview
10.4.2 Middle East and Africa Oral Anticoagulants Market Forecasts and Analysis
10.4.3 Middle East and Africa Oral Anticoagulants Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Oral Anticoagulants Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Oral Anticoagulants Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Oral Anticoagulants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oral Anticoagulants Market
10.4.6.1.1 South Africa Oral Anticoagulants Market by Product
10.4.6.1.2 South Africa Oral Anticoagulants Market by Indication
10.4.6.1.3 South Africa Oral Anticoagulants Market by Distribution Channel
10.4.6.2 Saudi Arabia Oral Anticoagulants Market
10.4.6.2.1 Saudi Arabia Oral Anticoagulants Market by Product
10.4.6.2.2 Saudi Arabia Oral Anticoagulants Market by Indication
10.4.6.2.3 Saudi Arabia Oral Anticoagulants Market by Distribution Channel
10.4.6.3 U.A.E Oral Anticoagulants Market
10.4.6.3.1 U.A.E Oral Anticoagulants Market by Product
10.4.6.3.2 U.A.E Oral Anticoagulants Market by Indication
10.4.6.3.3 U.A.E Oral Anticoagulants Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oral Anticoagulants Market Overview
10.5.2 South and Central America Oral Anticoagulants Market Forecasts and Analysis
10.5.3 South and Central America Oral Anticoagulants Market Forecasts and Analysis - By Product
10.5.4 South and Central America Oral Anticoagulants Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Oral Anticoagulants Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Oral Anticoagulants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oral Anticoagulants Market
10.5.6.1.1 Brazil Oral Anticoagulants Market by Product
10.5.6.1.2 Brazil Oral Anticoagulants Market by Indication
10.5.6.1.3 Brazil Oral Anticoagulants Market by Distribution Channel
10.5.6.2 Argentina Oral Anticoagulants Market
10.5.6.2.1 Argentina Oral Anticoagulants Market by Product
10.5.6.2.2 Argentina Oral Anticoagulants Market by Indication
10.5.6.2.3 Argentina Oral Anticoagulants Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORAL ANTICOAGULANTS MARKET, KEY COMPANY PROFILES
12.1. CIPLA LIMITED
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MEDICURE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EISAI CO., LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBOTT LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BOEHRINGER INGELHEIM GMBH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DAIICHI SANKYO COMPANY LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTRAZENECA, PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Cipla Limited
- Medicure
- Eisai Co., Ltd
- GlaxoSmithKline Plc
- Eli Lilly And Company
- Abbott Laboratories
- Boehringer Ingelheim GmbH
- Daiichi Sankyo Company Ltd
- Pfizer Inc
- AstraZeneca, PLC